HER2-positive Metastatic Breast Cancer trials recruiting in New York

Fewer than 3 recruiting trials found.

All HER2-positive Metastatic Breast Cancer trials nationally

Cities in New York

Recruiting trials in New York

• Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
  NCT06625775 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
  NCT06551116 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: The Bronx